EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The next‐generation therapies in ophthalmology for blindness worldwide

Jie Xu, Chang‐Jun Zhang, Jia‐Yi Jiang, Zi‐Bing Jin

Eye & ENT Research · 2024

DOI: 10.1002/eer3.4 ↗

At a glance

Journal article in Eye & ENT Research, 2024. Written by Jie Xu and 3 co-authors. Cited 3 times so far (Crossref); 160 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

With the rapid and groundbreaking development in 21st century medicine on a global scale, new possibilities have emerged for addressing eye diseases, that can be blindness, and that conventional pharmaceuticals and surgical interventions have not hitherto been able to adequately treat. Gene enhancement/supplementation, gene editing, and stem cell therapies have now emerged as key subdisciplines. Here we discuss the current state and prospects of regenerative therapy in the field of ophthalmology, with a primary focus on diseases affecting the cornea, retina, and optic nerve. Our review summarizes the latest advances, challenges, and opportunities in these fields, as well as the potential applications and limitations of different strategies. The review also highlights the importance of interdisciplinary and collaborative innovation models for achieving breakthroughs in therapeutic development for sight‐loss diseases worldwide.

Cite

APA

Xu, J., Zhang, C., Jiang, J., & Jin, Z. (2024). The next‐generation therapies in ophthalmology for blindness worldwide. Eye & ENT Research. https://doi.org/10.1002/eer3.4

Vancouver

Xu J, Zhang C, Jiang J, Jin Z. The next‐generation therapies in ophthalmology for blindness worldwide. Eye & ENT Research. 2024. doi:10.1002/eer3.4

BibTeX
@article{Xu2024,
  author = {Xu, Jie and Zhang, Chang‐Jun and Jiang, Jia‐Yi and Jin, Zi‐Bing},
  title = {The next‐generation therapies in ophthalmology for blindness worldwide},
  journal = {Eye & ENT Research},
  year = {2024},
  doi = {10.1002/eer3.4}
}
Start for free →